Uozumi R - Search Results

1

Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.

Masuda N, Bando H, Yamanaka T, Kadoya T, Takahashi M, Nagai SE, Ohtani S, Aruga T, Suzuki E, Kikawa Y, Yasojima H, Kasai H, Ishiguro H, Kawabata H, Morita S, Haga H, Kataoka TR, Uozumi R, Ohno S, Toi M. Masuda N, et al. Among authors: uozumi r. Breast Cancer Res Treat. 2021 Jul;188(1):117-131. doi: 10.1007/s10549-021-06184-w. Epub 2021 Mar 25. Breast Cancer Res Treat. 2021. PMID: 33763789 Free PMC article. Clinical Trial.

2

Low Body Weight Is Associated With the Incidence of Stroke in Atrial Fibrillation Patients - Insight From the Fushimi AF Registry.

Hamatani Y, Ogawa H, Uozumi R, Iguchi M, Yamashita Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Abe M, Morita S, Akao M. Hamatani Y, et al. Among authors: uozumi r. Circ J. 2015;79(5):1009-17. doi: 10.1253/circj.CJ-14-1245. Epub 2015 Feb 13. Circ J. 2015. PMID: 25740669 Free article. Clinical Trial.

3

The Long-term Clinical Course of Chronic Eosinophilic Pneumonia.

Ishiguro T, Takayanagi N, Uozumi R, Tada M, Kagiyama N, Takaku Y, Shimizu Y, Sugita Y, Morita S. Ishiguro T, et al. Among authors: uozumi r. Intern Med. 2016;55(17):2373-7. doi: 10.2169/internalmedicine.55.6765. Epub 2016 Sep 1. Intern Med. 2016. PMID: 27580536 Free article.

4

Risk factors for the severity and mortality of pneumococcal pneumonia: Importance of premorbid patients' performance status.

Ishiguro T, Kagiyama N, Uozumi R, Odashima K, Kurashima K, Morita S, Takayanagi N. Ishiguro T, et al. Among authors: uozumi r. J Infect Chemother. 2016 Oct;22(10):685-91. doi: 10.1016/j.jiac.2016.07.008. Epub 2016 Sep 1. J Infect Chemother. 2016. PMID: 27593263

5

Current Status and Outcomes of Direct Oral Anticoagulant Use in Real-World Atrial Fibrillation Patients　- Fushimi AF Registry.

Yamashita Y, Uozumi R, Hamatani Y, Esato M, Chun YH, Tsuji H, Wada H, Hasegawa K, Ogawa H, Abe M, Morita S, Akao M. Yamashita Y, et al. Among authors: uozumi r. Circ J. 2017 Aug 25;81(9):1278-1285. doi: 10.1253/circj.CJ-16-1337. Epub 2017 Apr 19. Circ J. 2017. PMID: 28428449 Free article. Clinical Trial.

6

Clinical Characteristics of Influenza-Associated Pneumonia of Adults: Clinical Features and Factors Contributing to Severity and Mortality.

Ishiguro T, Kagiyama N, Uozumi R, Odashima K, Takaku Y, Kurashima K, Morita S, Takayanagi N. Ishiguro T, et al. Among authors: uozumi r. Yale J Biol Med. 2017 Jun 23;90(2):165-181. eCollection 2017 Jun. Yale J Biol Med. 2017. PMID: 28656006 Free PMC article.

7

Combined effects of neoadjuvant letrozole and zoledronic acid on γδT cells in postmenopausal women with early-stage breast cancer.

Sugie T, Suzuki E, Yamauchi A, Yamagami K, Masuda N, Gondo N, Sumi E, Ikeda T, Tada H, Uozumi R, Kanao S, Tanaka Y, Hamazaki Y, Minato N, Toi M. Sugie T, et al. Among authors: uozumi r. Breast. 2018 Apr;38:114-119. doi: 10.1016/j.breast.2017.12.017. Epub 2018 Jan 5. Breast. 2018. PMID: 29310035 Clinical Trial.

8

Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients.

Suzuki E, Sugimoto M, Kawaguchi K, Pu F, Uozumi R, Yamaguchi A, Nishie M, Tsuda M, Kotake T, Morita S, Toi M. Suzuki E, et al. Among authors: uozumi r. Breast Cancer. 2019 May;26(3):282-289. doi: 10.1007/s12282-018-0920-2. Epub 2018 Oct 13. Breast Cancer. 2019. PMID: 30317464

9

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer.

Hattori Y, Kono Y, Itoh S, Inoue T, Urata Y, Kawa Y, Tohnai R, Kumagai T, Nishino K, Uozumi R, Morita S, Negoro S, Imamura F, Satouchi M. Hattori Y, et al. Among authors: uozumi r. BMC Cancer. 2020 Feb 11;20(1):115. doi: 10.1186/s12885-020-6588-y. BMC Cancer. 2020. PMID: 32046667 Free PMC article. Clinical Trial.

10

The Rate of Apparent Diffusion Coefficient Change With Diffusion Time on Breast Diffusion-Weighted Imaging Depends on Breast Tumor Types and Molecular Prognostic Biomarker Expression.

Iima M, Kataoka M, Honda M, Ohashi A, Ohno Kishimoto A, Ota R, Uozumi R, Urushibata Y, Feiweier T, Toi M, Nakamoto Y. Iima M, et al. Among authors: uozumi r. Invest Radiol. 2021 Aug 1;56(8):501-508. doi: 10.1097/RLI.0000000000000766. Invest Radiol. 2021. PMID: 33660629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters